Nanologica operates in the field of nanotechnology. Currently the main business focus is on the sectors Drug Delivery and Chromatography, which includes the development of pharmaceutical administration and technology used for the separation and purification of products. The research is carried out in collaboration with Stockholm University and the Ångström Laboratory at Uppsala University. The company was founded in 2004 and is based in Södertälje.

Quotes for Nanologica AB

Right Now

+/-
-0.35
%
-2,46%
Latest
13.85
High
14
Low
13.85
Volume
17 199
Turnover (SEK)
238 811
Value (MSEK)
390,1

Board

CEO

  • Andreas Bhagwani

Chairperson of the Board

  • Gisela Sitbon

Board

  • Anders Rabbe
  • Eva Byröd
  • Lena Torlegård
  • Mattias Bengtsson
  • Thomas Eldered
  • Tomas Kramar

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 32,32 32,32 2021-03-31
Swedbank Robur Fonder 9,23 9,23 2021-09-30
Andreas Bhagwani 7,15 7,15 2021-09-30
Avanza Pension 4,78 4,78 2021-09-30
Kungliga Konstakademien 4,15 4,15 2021-09-30
Niklas Sjöblom 1,93 1,93 2021-09-30
Mikael Lönn 1,78 1,78 2021-09-30
Alfonso Garcia-Bennett 1,72 1,72 2021-09-30
Nordic Cross Asset Management 1,46 1,46 2021-08-31
Nordnet Pensionsförsäkring 1,22 1,22 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream